Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

NCT01539707 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder
Neurogenic Detrusor Overactivity

Interventions

DRUG: Solifenacin succinate suspension 5 mg

Sponsor

Astellas Pharma Inc